Chronic obstructive pulmonary disease Trials in Edina, United States
Conditions / Chronic obstructive pulmonary disease / Edina, United States
Research into Chronic obstructive pulmonary disease spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01854645 | Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1) | COMPLETED | PHASE3 |
| NCT02343458 | Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD | COMPLETED | PHASE3 |
| NCT02796677 | AMPLIFY - D6571C00001 Duaklir USA Phase III Study | COMPLETED | PHASE3 |
| NCT00970268 | Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36) | COMPLETED | PHASE3 |
| NCT00206167 | A Comparison of Symbicort® pMDI 2 x 160/4.5 μg Bid and 2 x 80/4.5 μg Bid With Formoterol Turbuhaler® 2 x 4.5 μg Bid and Placebo in Patients With COPD | COMPLETED | PHASE3 |
| NCT01045161 | Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38) | COMPLETED | PHASE3 |
| NCT01572792 | Efficacy, Safety and Tolerability of Two Fixed Dose Combinations of Aclidinium Bromide/Formoterol Fumarate, Aclidinium Bromide, Formoterol Fumarate and Placebo for 28-Weeks Treatment in Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT01437397 | Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00624286 | Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) | COMPLETED | PHASE3 |
| NCT00891462 | Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33) | COMPLETED | PHASE3 |